Angiotensin Receptor/Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor Use in Patients With a Left Ventricular Assist Device: A Propensity Score Matched Analysis

Authors

Bharat Rawlley
Andres Cordova Sanchez
Kartik Gupta, Henry Ford HealthFollow
Matthew Ramm
Debanik Chaudhuri

Recommended Citation

Rawlley B, Sanchez AC, Gupta K, Ramm M, and Chaudhuri D. Angiotensin Receptor/Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor Use in Patients With a Left Ventricular Assist Device: A Propensity Score Matched Analysis. Am J Cardiol 2023; 211:180-182.

Document Type

Article

Publication Date

1-15-2024

Publication Title

The American journal of cardiology

Medical Subject Headings

Humans; Angiotensin-Converting Enzyme Inhibitors; Neprilysin; Heart-Assist Devices; Propensity Score; Valsartan; Heart Failure; Receptors, Angiotensin; Aminobutyrates; Angiotensin Receptor Antagonists; Drug Combinations; Tetrazoles; Stroke Volume

PubMed ID

37866448

Volume

211

First Page

180

Last Page

182